FDA campaign H-1263-2026
Class IHazard
The product contains 1,4-DMAA, Phenylethylamine and Phenibut.
Distribution
The firm markets their products online via their website addallxr.com
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.